Corneal Neovascularization
Recent clinical, regulatory, research and industry developments relating to this disease.
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial expected to report results, the earliest in Q4 2026.
Clinical MilestonesViewHide
- 2026-01-09Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.Results expected Q4 2026
- 2026-01-09ClinicalClinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.Results expected Q4 2026
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes5
- Corneal Neovascularization1
- CRISPR-Cas Systems1
- Gene Editing1
- Human Umbilical Vein Endothelial Cells1
- Vascular Endothelial Growth Factor A1
Leading journals1
- Advanced science (Weinheim, Baden-Wurttemberg, Germany)1
Leading researchers8
- Chen L1
- Chen X1
- Chen Z1
- Huang J1
- Lei H1
- Li S1
- Lin M1
- McAlinden C1
Affiliations (unnormalised)6
- 2nd Affiliated Hospital of Nanchang University1
- Eye Institute and Department of Ophthalmology1
- Key Laboratory for Regenerative Medicine1
- Queen Victoria Hospital1
- School of Ophthalmology and Optometry and Eye Hospital1
- Shanghai Key Laboratory of Visual Impairment and Restoration1
Reference
Authoritative identity, definition & identifiers.
New blood vessels originating from the corneal blood vessels and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.